Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > My personal question: What will come first, M&A activity or
View:
Post by subaru1i on Aug 14, 2023 12:30pm

My personal question: What will come first, M&A activity or

the drug monograph?    I ask this because we don't have to wait for a drug monograph from the FDA for ANY type of M&A, including M&A activity with their global pharma partner.   With that said, anything could happen now at any time.   

OH, ps: Congratulation to the LABS team on a great quarter, didn't want press *1 on the CC just to say that :-)
Comment by okgonow on Aug 14, 2023 12:42pm
was amazed no one asked about ongoing trials, german/EU buissness, the Braziian stuff, and FDA response to the stuff sent after inspection
Comment by subaru1 on Aug 14, 2023 1:40pm
and also why management doesn't put emphasis on that instead of waiting for question on these subject.
Comment by Vikingstock on Aug 14, 2023 2:52pm
Where you on the call this morning? I think their direction was as good as you will get in a public co., across cost reduction, market opportunities, mergers acquisitions in right circumstances, and money from real estate sale and court case. 
Comment by subaru1i on Aug 14, 2023 3:54pm
Yes but did not ask any questions...stayed quiet.   But they have my first name, representing 'Athea Investments'.   They'll connect those dots.  One interesting thing Pidduck mentioned during the CC even after the earnings P.R. stated these as separate items, being the Hexo settlement and real estate sale...we know about those things from the P.R. but what ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities